Loading…
Reported covered position: Health Policy Advisor to Senator Chuck Grassley; Acting Health Policy Director for Senator Chuck Grassley
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2019 · first_quarter · 1T
Discussing provider reimbursement issues and proposed demonstration project relating to CMMI
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ML STRATEGIES, LLC
2019 · first_quarter · 1T
Source: Senate LDA
| NATIONAL ASSOCIATION OF COUNTIES |
| 10 |
| 2017–2019 |
| THE JEWISH FEDERATIONS OF NORTH AMERICA | 10 | 2017–2018 |
| UNITYPOINT HEALTH | 7 | 2017–2019 |
| LINK-IN BENEFITS | 6 | 2017–2018 |
| CVS HEALTH | 5 | 2018–2019 |
| AMERICAN HOSPITAL ASSOCIATION | 3 | 2016–2017 |
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
Bipartisan Budget Act of 2018
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
Bipartisan Budget Act of 2018
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
Bipartisan Budget Act of 2018
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Bipartisan Budget Act of 2018
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Bipartisan Budget Act of 2018
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. The Bipartisan Budget Act of 2018, Omnibus.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
FAST Generics Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. The Bipartisan Budget Act of 2018, Omnibus.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Fair Accountability and Innovative Research Drug Pricing Act of 2017
Client: THE CAMPAIGN FOR SUSTAINABLE RX PRICING · Firm: ML STRATEGIES, LLC
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Closing Loopholes for Orphan Drugs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Closing Loopholes for Orphan Drugs Act
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Closing Loopholes for Orphan Drugs Act
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Closing Loopholes for Orphan Drugs Act
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology.
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, S. 2227 EMPOWER Care Act, H.R. 3331, and issues relating to opioid legislation (H.R. 6).
To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology.
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology.
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, S. 2227 EMPOWER Care Act, H.R. 3331, and issues relating to opioid legislation (H.R. 6).
To amend title XI of the Social Security Act to promote testing of incentive payments for behavioral health providers for adoption and use of certified electronic health record technology.
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
HEALTHY KIDS Act
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
HEALTHY KIDS Act
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
HEALTHY KIDS Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
HEALTHY KIDS Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: ASSOCIATION FOR COMMUNITY AFFILIATED PLANS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: THE JEWISH FEDERATIONS OF NORTH AMERICA · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Continuing Community Health And Medical Professional Programs to Improve Our Nation, Increase National Gains, and Help Ensure Access for Little Ones, Toddlers, and Hopeful Youth by Keeping Insurance Delivery Stable Act of 2017
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: NATIONAL ASSOCIATION OF COUNTIES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: AMERICA'S ESSENTIAL HOSPITALS · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
To provide that the provision of the Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems and Quality Reporting Programs final regulation relating to changes in the payment amount for certain drugs and biologicals purchased under the 340B drug discount program shall have no force or effect, and for other purposes.
Client: 340B HEALTH · Firm: ML STRATEGIES, LLC
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, HR 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S 2227 and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
EMPOWER Care Act
Client: AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES · Firm: ML STRATEGIES, LLC
General issues relating to Medicare and Medicaid, HR 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S 2227 and HR 5306 EMPOWER Care Act
General issues relating to PBMs and drug pricing
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2019 · first_quarter · 1T
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2019 · first_quarter · 1T
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2019 · first_quarter · 1T
General issues relating to Medicare and Medicaid
General issues relating to Medicare and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2019 · first_quarter · 1T
Issues relating to 340B
Issues relating to 340B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2019 · first_quarter · 1T
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2019 · first_quarter · 1T
Issues related to prescription drug pricing
Issues related to prescription drug pricing
Issues related to prescription drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Discussing provider reimbursement issues and proposed demonstration project relating to CMMI
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
General issues relating to Medicare and Medicaid, HR 5306 EMPOWER Care Act, and Medicaid incentive payments
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
CVS HEALTH via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Intel gathering or on behalf of and influencingopioid legislation (HR 6); general issues relating to PBMs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Prescription drug pricing. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, and HR 5306 EMPOWER Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
General issues relating to Medicare and Medicaid
General issues relating to Medicare and Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Issues relating to 340B
Issues relating to 340B
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2018 · fourth_quarter · Q4
Issues related to the FDA oversight of medical device servicing and remanufacturing.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2018 · third_quarter · Q3
Issues related to the FDA oversight of medical device servicing and remanufacturing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2018 · third_quarter · Q3
MEND Act (HR662). Discussing provider reimbursement issues and proposed demonstration project relating to CMMI
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2018 · third_quarter · Q3
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
General issues relating to Medicare and Medicaid, issues relating to opioid legislation (HR 6), issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2018 · third_quarter · Q3
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
General issues relating to Medicare and Medicaid, S 2227 and HR 5306 EMPOWER Care Act, HR 3331, and issues relating to opioid legislation (HR 6)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ML STRATEGIES, LLC
2018 · third_quarter · Q3
Issues relating to opioid legislation (HR 6); general issues relating to PBMs
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2018 · third_quarter · Q3
Prescription drug pricing. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. H.R.6 - SUPPORT for Patients and Communities Act. S. 3120 - HEAL Act of 2018. S. 2553: Know the Lowest Price Act of 2018. S. 2554: Patient Right to Know Drug Prices Act.
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2018 · third_quarter · Q3
General issues relating to Medicare and Medicaid, HR 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S 2227 and HR 5306 EMPOWER Care Act
General issues relating to Medicare and Medicaid, HR 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S 2227 and HR 5306 EMPOWER Care Act
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2018 · third_quarter · Q3
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans , issues relating to opioid legislation (HR 6)
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans , issues relating to opioid legislation (HR 6)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2018 · third_quarter · Q3
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2018 · third_quarter · Q3
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Issues: Issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, HR 6071, HR 2889, HR 5598, HR 6240, and HR 6273
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2018 · second_quarter · 2T
Issues relating to Medicare Advantage.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2018 · second_quarter · Q2
General issues relating to Medicare and Medicaid, S. 2227 EMPOWER Care Act, H.R. 3331, and issues relating to opioid legislation (H.R. 6).
General issues relating to Medicare and Medicaid, S. 2227 EMPOWER Care Act, H.R. 3331, and issues relating to opioid legislation (H.R. 6).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ML STRATEGIES, LLC
2018 · second_quarter · Q2
General issues relating to PBMs and prescription drug pricing, and issues relating to opioid legislation (H.R. 6).
Filing targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2018 · second_quarter · Q2
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Prescription drug pricing. Medicare Part D Biosimilars.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2018 · second_quarter · Q2
General issues relating to Medicare and Medicaid, H.R. 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S. 2227 EMPOWER Care Act.
General issues relating to Medicare and Medicaid, H.R. 6042 (To amend title XIX of the Social Security Act to delay the reduction in Federal medical assistance percentage for Medicaid personal care services furnished without an electronic visit verification system, and for other purposes), issues relating to electronic visit verification, S. 2227 EMPOWER Care Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2018 · second_quarter · Q2
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
General issues relating to Medicare and Medicaid, issues relating to 340B including S. 2453, S. 2312, H.R. 4710, H.R. 4392, and H.R. 6071.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2018 · second_quarter · Q2
Issues related to the FDA oversight of medical device servicing.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2018 · second_quarter · Q2
MEND Act (HR662). Discussing provider reimbursement issues and proposed demonstration project relating to CMMI
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2018 · second_quarter · Q2
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
General issues relating to Medicare and Medicaid, issues relating to 340B including S 2453, S2312, HR 4710, HR 4392, and HR 6071.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2018 · second_quarter · Q2
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Issues relating to Medicaid, Medicare, and the Marketplace, Short-term limited duration insurance plans, and association health plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2018 · second_quarter · Q2
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392 and HR 6071.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2018 · first_quarter · Q1
Medicare provider billing issues, Medicare pass-through funding for nursing colleges (HR 662), Next Generation ACO changes.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2018 · first_quarter · Q1
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2018 · first_quarter · Q1
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2018 · first_quarter · Q1
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2018 · first_quarter · Q1
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, and H.R. 1892.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2018 · first_quarter · Q1
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
General issues relating to Medicare and Medicaid and the Marketplace, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, Alexander/Murray stabilization, S.1835 - Lower Premiums Through Reinsurance Act of 2017, and Short-term limitation duration insurance plans and association health plans
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2018 · first_quarter · Q1
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars. The Bipartisan Budget Act of 2018, Omnibus.
Prescription drug pricing. Medicare Part D Biosimilars. The Bipartisan Budget Act of 2018, Omnibus.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017. Medicare Part D Biosimilars.
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2018 · first_quarter · Q1
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
General issues relating to Medicare and Medicaid, H.R.3922 Championing Health Kids, S. 1827 the KIDS Act, H.R.3921 HEALTHY KIDS Act, H.R. 1892, issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2018 · first_quarter · Q1
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Issues relating to 340B including S 2453, S 2312, HR 4710, and HR 4392.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2018 · first_quarter · Q1
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CVS HEALTH via ML STRATEGIES, LLC
2018 · second_quarter · RR
Issues related to PBMs and opioid policy.
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues related to Medicare.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), issues relating to 340B and H.R. 4392, the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), issues relating to 340B and H.R. 4392, the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare, Medicaid, and the Marketplace.
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare, Medicaid, and the Marketplace.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars.
Prescription drug pricing. S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act. H.R. 2051 - FAST Generics Act of 2017 Medicare Part D Biosimilars.
Prescription drug pricing. Medicare Part D Biosimilars.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), issues relating to 340B and H.R. 4392, and the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
General issues relating to the American Health Care Act (H.R. 1628),the Better Care Reconciliation Act (H.R. 1628),the Graham-Cassidy bill (Amendment to H.R. 1628), issues relating to 340B and H.R. 4392, and the Tax Reform and Jobs Act (H.R. 1), and general issues relating to Medicare and Medicaid.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
General issues relating to 340B, and H.R. 4392.
General issues relating to 340B, and H.R. 4392.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2017 · fourth_quarter · Q4
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
UNITYPOINT HEALTH via ML STRATEGIES, LLC
2017 · fourth_quarter · RR
General issues related to Medicare
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicare, Medicaid
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicare, Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Issues related to prescription drug pricing; S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Issues related to prescription drug pricing.
Issues related to prescription drug pricing; S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicaid, Medicare
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicaid, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2017 · third_quarter · Q3
General issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628)
General issues pertaining to availability of premium tax credits for enrollees in the Federally Facilitated Marketplace and added cost sharing reductions (CSR)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2017 · third_quarter · Q3
General issues pertaining to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628)
General issues pertaining American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2017 · third_quarter · Q3
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicare, Medicaid
Issues related to American Health Care Act,the Better Care Reconciliation Act and the Graham-Cassidy bill (H.R. 1628); Medicaid, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2017 · third_quarter · Q3
General issues relating to 340B.
General issues relating to 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Issues related to the American Health Care Act and the Better Care Reconciliation Act; Medicaid, Medicare
Issues related to the American Health Care Act and the Better Care Reconciliation Act; Medicaid, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Helping develop federal advocacy strategy with CMS regarding Medicare Advantage issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Issues related to the American Health Care Act and the Better Care Reconciliation Act; Medicare, Medicaid
Issues related to the American Health Care Act and the Better Care Reconciliation Act; Medicare, Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Issues related to American Health Care Act and the Better Care Reconciliation Act; Medicare, Medicaid
Issues related to American Health Care Act and the Better Care Reconciliation Act; Medicaid, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2017 · second_quarter · Q2
General issues pertaining to availability of premium tax credits for enrollees in the Federally Facilitated Marketplace and added cost sharing reductions (CSR)
General issues pertaining to the American Health Care Act and the Better Care Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Issues related to prescription drug pricing; S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Issues related to prescription drug pricing; S. 974 - CREATES Act. S. 1131 and H.R. 2439 - Fair Accountability and Innovative Research Drug Pricing Act S. 934 and H.R. 2430 - FDA Reauthorization Act of 2017 H.R. 2051 - FAST Generics Act of 2017
Issues related to prescription drug pricing.
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2017 · second_quarter · Q2
General issues pertaining to American Health Care Act and the Better Care Reconciliation Act
General issues pertaining to American Health Care Act and the Better Care Reconciliation Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2017 · second_quarter · Q2
General issues relating to 340B.
General issues relating to 340B.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2017 · second_quarter · Q2
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
LINK-IN BENEFITS via ML STRATEGIES, LLC
2017 · second_quarter · RR
Goal of receiving CMS stated approval to use VA (Veterans Affairs) data for Medicare Advantage risk adjustment.
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2017 · first_quarter · Q1
Issues related to American Health Care Act; Medicare, Medicaid
Issues related to American Health Care Act; Medicaid, Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2017 · first_quarter · Q1
Issues related to Health care reform; American Health Care Act, Medicaid; Medicare
Issues related to Health care reform; American Health Care Act, Medicaid; Medicare
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · first_quarter · 1A
Issues related to the American Health Care Act and Health Care reform; Medicare; Medicaid
Issues related to the American Health Care Act and Health Care reform; Medicare; Medicaid
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · first_quarter · Q1
General issues pertaining to the American Health Care Act
Issues related to the American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · first_quarter · Q1
Issues related to the American Health Care Act
General issues pertaining to the American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2017 · first_quarter · Q1
Issues related to prescription drug pricing; S. 3056 - CREATES Act
Issues related to prescription drug pricing; S. 3056 - CREATES Act
Issues related to prescription drug pricing
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2017 · first_quarter · Q1
General issues pertaining to American Health Care Act
General issues pertaining to American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2017 · first_quarter · Q1
General issues pertaining to availability of premium tax credits for enrollees in the Federally Facilitated Marketplace and added cost sharing reductions (CSR)
General issues pertaining to the American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2017 · first_quarter · Q1
General issues pertaining to the American Health Care Act
General issues pertaining to the American Health Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2017 · first_quarter · Q1
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN NETWORK OF COMMUNITY OPTIONS AND RESOURCES via ML STRATEGIES, LLC
2017 · first_quarter · RR
Funding for Medicaid HCBS programs, support for direct support professionals in disability field, equal rights for people with disabilities; ACHA
Funding for Medicaid HCBS programs, support for direct support professionals in disability field, equal rights for people with disabilities; ACHA
THE JEWISH FEDERATIONS OF NORTH AMERICA via ML STRATEGIES, LLC
2017 · first_quarter · RR
Health Reform; Improving Medicare Post-Acute Care Transformation Act of 2014; American Health Care Act; Medicaid; Medicare
Health Reform; Improving Medicare Post-Acute Care Transformation Act of 2014; American Health Care Act; Medicaid; Medicare
NATIONAL ASSOCIATION OF COUNTIES via ML STRATEGIES, LLC
2017 · first_quarter · RR
Health care Reform; AHCA, Medicaid
Health care Reform; AHCA, Medicaid
AMERICAN HOSPITAL ASSOCIATION via ML STRATEGIES, LLC
2017 · first_quarter · 1T
Issues related to Affordable Care Act (ACA)
Filing targets: SENATE
AMERICA'S ESSENTIAL HOSPITALS via ML STRATEGIES, LLC
2017 · first_quarter · RR
Health care reform; 340 B drug discount program; Medicaid funding for public hospitals
Health care reform; 340 B drug discount program; Medicaid funding for public hospitals
AMERICAN HOSPITAL ASSOCIATION via ML STRATEGIES, LLC
2016 · fourth_quarter · Q4
Issues related to federal Hospital Outpatient Department (HOPD) and 340B Drug Discount Program
Issues related to Hospital Outpatient Department (HOPD) and 340B Drug Discount Program
Filing targets: HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
THE CAMPAIGN FOR SUSTAINABLE RX PRICING via ML STRATEGIES, LLC
2016 · fourth_quarter · Q4
Issues related to transparency and competition in the prescription drug market
Issues related to transparency and competition in the prescription drug market; FDA appropriations; S. 3056 - CREATES Act, S. 3335 Fair Drug Pricing Act; 21st century cures
Issues related to transparency and competition in the prescription drug market; FDA appropriations; S. 3056 - CREATES Act, S. 3335 Fair Drug Pricing Act; 21st century cures
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2016 · fourth_quarter · Q4
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
340B HEALTH via ML STRATEGIES, LLC
2016 · fourth_quarter · RR
The 340B Drug Discount Program
The 340B Drug Discount Program
ASSOCIATION FOR COMMUNITY AFFILIATED PLANS via ML STRATEGIES, LLC
2016 · fourth_quarter · RR
General issues related to promoting transparency, competition and value in the prescription drug market.
General issues related to promoting transparency, competition and value in the prescription drug market.
KARL STORZ ENDOSCOPY - AMERICA, INC via ML STRATEGIES, LLC
2016 · third_quarter · Q3
Issues related to the FDA regulation of third-party repair of medical devices.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
The Bipartisan Budget Act of 2018, Omnibus.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE